logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Prostatic Hyperplasia

    FiltersReset Filters
    17 results

    • doxazosin

      (Doxazosin Mesylate)
      Upsher-Smith laboratories, LLC
      Usage: Doxazosin tablets are indicated for treating benign prostatic hyperplasia (BPH) symptoms and for lowering blood pressure in hypertension, reducing the risk of cardiovascular events like strokes and myocardial infarctions. It can be used alone or with other antihypertensives as part of comprehensive cardiovascular management.

    • doxazosin

      (doxazosin mesylate)
      Aurobindo Pharma Limited
      Usage: Doxazosin is indicated for the treatment of benign prostatic hyperplasia (BPH) and hypertension. It helps relieve BPH symptoms and lowers blood pressure, reducing the risk of cardiovascular events such as strokes and heart attacks. It can be used alone or in combination with other antihypertensive medications.

    • doxazosin

      (Doxazosin)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Doxazosin tablets are indicated for treating benign prostatic hyperplasia (BPH) and hypertension. It helps lower blood pressure, reducing the risk of cardiovascular events such as strokes and myocardial infarctions. Doxazosin can be used alone or in combination with other antihypertensive medications.

    • dutasteride

      (Dutasteride)
      MARKSANS PHARMA LIMITED
      Usage: Dutasteride Capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men, aimed at improving symptoms, reducing the risk of acute urinary retention, and minimizing the need for BPH-related surgery. They can be used alone or with tamsulosin but are not approved for prostate cancer prevention.

    • dutasteride

      (Dutasteride)
      Epic Pharma, LLC
      Usage: Dutasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men, either as monotherapy to improve symptoms and reduce complications, or in combination with tamsulosin. It is not approved for prostate cancer prevention.

    • dutasteride and tamsulosin hydrochloride

      (Dutasteride and tamsulosin hydrochloride)
      Zydus Pharmaceuticals USA Inc.
      Usage: Dutasteride and tamsulosin hydrochloride capsules are indicated for treating symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. They are not approved for prostate cancer prevention.

    • finasteride

      (Finasteride)
      Ascend Laboratories, LLC
      Usage: Finasteride tablets are indicated for treating symptomatic benign prostatic hyperplasia (BPH) in men, improving symptoms, reducing acute urinary retention risk, and surgical need. It can be combined with the alpha-blocker doxazosin to mitigate BPH progression. Note: Not approved for prostate cancer prevention.

    • silodosin

      (silodosin)
      Creekwood Pharmaceuticals LLC
      Usage: Silodosin is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH). It is not intended for treating hypertension.

    • tadalafil

      (tadalafil)
      Unichem Pharmaceuticals (USA), Inc.
      Usage: Tadalafil Tablets are indicated for the treatment of erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and both ED and BPH (ED/BPH). Use with finasteride for BPH treatment is recommended for up to 26 weeks due to decreasing incremental benefits beyond this period.

    • tadalafil

      (tadalafil)
      Alembic Pharmaceuticals Limited
      Usage: Tadalafil tablets USP are indicated for the treatment of erectile dysfunction (ED) and the signs and symptoms of benign prostatic hyperplasia (BPH). The combination use with finasteride for BPH is recommended for up to 26 weeks due to decreasing benefit over time.